首页> 外文会议>World congress on medical physics and biomedical engineering >In-Phantom Peripheral Organ Doses from Prostate Irradiation Using 18 MV External Beam Radiotherapy Measured with 6LiF:Mg,Cu,P 7LiF:Mg,Cu,P Glass-Rod TLDs
【24h】

In-Phantom Peripheral Organ Doses from Prostate Irradiation Using 18 MV External Beam Radiotherapy Measured with 6LiF:Mg,Cu,P 7LiF:Mg,Cu,P Glass-Rod TLDs

机译:用6LIF:Mg,Cu,P&7LIF:Mg,Cu,P玻璃棒TLD测量的18 MV外梁放射疗法,使用18 MV外梁放射疗法,来自前列腺辐射的内周外器官剂量。

获取原文

摘要

A radiation dosimetry technique based on pairs of LiF:Mg,Cu,P and ~7LiF:Mg,Cu,P glass-rod TLDs was developed for measuring peripheral photon and neutron doses in the humanoid Rando phantom as a result of prostate irradiation using the 18 MV three-dimensional conformal radiotherapy (3D-CRT). The peripheral doses for different organs were estimated from TLD measurements and the risks of radiation-induced second malignancy were estimated using the competitive risk and linear no-threshold models. It was observed that following 80 Gy prostate irradiation using 18 MV 3D-CRT technique, both photons and neutrons doses ranged from approximately 97 mSv (in thyroid) to 807 mSv (in colon). Using the competitive risk model, the estimated risk of second malignancy was found to be ranging from 0.5% (for lungs) to 3.3% (for colon). Due to low doses (<2 Gy) exposure, estimation of the risk of second malignancy using the linear no-threshold model resulted in similar values as obtained with the competitive risk model. In conclusion, 6LiF:Mg,Cu,P and 7LiF:Mg,Cu,P glass-rod TLDs can be used in pairs to enable determination of photon and neutron doses simultaneously in a Rando phantom and to evaluate the impact of prostate cancer irradiation with high-energy (18 MV) 3D-CRT technique on the risk of second malignancy in various organs.
机译:基于LIF对的辐射剂量测定技术:Mg,Cu,P和〜7LIF:Mg,Cu,P玻璃棒TLD被开发用于测量人形Rando Phantom中的外周光子和中子剂量,因此使用前列腺辐射18 MV三维保形放疗(3D-CRT)。从TLD测量估计不同器官的外周剂量,使用竞争风险和线性无阈值模型估计辐射引起的第二恶性肿瘤的风险。观察到,在使用18mV 3D-CRT技术的80 Gy前列腺照射之后,光子和中源剂量的剂量从大约97msv(在甲状腺中)至807msv(在结肠中)。使用竞争风险模型,发现第二恶性肿瘤的估计风险从0.5%(肺部)到3.3%(用于结肠)。由于低剂量(<2GY)曝光,使用线性无阈值模型估计第二恶性阈值模型的风险导致与竞争风险模型获得的类似值。总之,6LIF:Mg,Cu,P和7LIF:Mg,Cu,P玻璃棒TLD可以成对使用,以便在Rando Phantom中同时测定光子和中子剂量,并评估前列腺癌辐照的影响高能量(18 MV)3D-CRT技术,涉及各种器官第二恶性肿瘤的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号